Tau Protein Is Associated With Longitudinal Memory Decline in Cognitively Healthy Subjects With Normal Alzheimer’s Disease Cerebrospinal Fluid Biomarker Levels

Journal of Alzheimer's Disease - Netherlands
doi 10.3233/jad-190046
Full Text
Abstract

Available in full text

Date
Authors
Publisher

IOS Press

Related search

GWAS of Cerebrospinal Fluid Tau Levels Identifies Risk Variants for Alzheimer’s Disease

Neuron
Neuroscience
2013English

APOE- 4 Is Associated With Memory Decline in Cognitively Impaired Elderly

Neurology
Neurology
2000English

Cerebrospinal Fluid PKR Level Predicts Cognitive Decline in Alzheimer’s Disease

PLoS ONE
Multidisciplinary
2013English

Increased Oxidative Stress Markers in Cerebrospinal Fluid From Healthy Subjects With Parkinson’s Disease-Associated LRRK2 Gene Mutations

Frontiers in Aging Neuroscience
AgingCognitive Neuroscience
2017English

Increased Levels of Cerebrospinal Fluid JNK3 Associated With Amyloid Pathology: Links to Cognitive Decline

Journal of Psychiatry and Neuroscience
MedicinePsychiatryBiological PsychiatryMental HealthPharmacology
2015English

Longitudinal Assessment of Tau and Amyloid Beta in Cerebrospinal Fluid of Parkinson Disease

Acta Neuropathologica
Forensic MedicineMolecular NeurosciencePathologyNeurologyCellular
2013English

Cerebrospinal Fluid Glutamic Oxaloacetic Transaminase and Lactate Dehydrogenase Levels in Alzheimer’s Disease

Saudi Journal of Biomedical Research
2020English

24s-Hydroxycholesterol Correlates With Tau and Is Increased in Cerebrospinal Fluid in Parkinson's Disease and Corticobasal Syndrome

Frontiers in Neurology
Neurology
2018English

Alzheimer’s Disease Risk Variants Show Association With Cerebrospinal Fluid Amyloid Beta

Neurogenetics
Molecular NeuroscienceGeneticsCellular
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy